 |
市場調查報告書
商品編碼
1672939
水凝膠藥物傳輸系統市場按來源、應用、輸送途徑、最終用戶和地區分類Hydrogel-Based Drug Delivery System Market, By Source, By Application, By Route of Delivery, By End User, By Geography |
||||||
2025 年全球基於水凝膠的藥物輸送系統市場規模估計為 84.9 億美元，預計到 2032 年將達到 134.7 億美元，2025 年至 2032 年的複合年成長率為 6.8%。
| 報告範圍 | 報告詳細資訊 | ||
|---|---|---|---|
| 基準年 | 2024 | 2025 年市場規模 | 84.9 億美元 |
| 效能資料 | 從 2020 年到 2024 年 | 預測期 | 2025 至 2032 年 |
| 預測期：2025-2032年複合年成長率： | 6.80% | 2032 年價值預測 | 134.7億美元 |
基於水凝膠的藥物遞送系統是一種新興技術，利用水凝膠作為藥物包封和遞送的載體。水凝膠是一種親水性聚合物網路，可以吸收大量的水或生物液體，同時保持其結構。水凝膠模仿天然細胞外基質，可以封裝細胞和藥物，達到持續、局部釋放。基於水凝膠的傳輸的優點包括保護藥物免於分解、控制釋放動力學以延長治療活性、改善位點特異性靶向性以及與生物系統的兼容性。業界正在積極研究各種藥物的水凝膠配方以及組織工程、創傷治療和生物感測領域的新應用。
市場動態：
基於水凝膠的藥物傳輸系統市場主要受到對局部和持續藥物傳輸日益成長的需求的推動。水凝膠能夠以控制釋放的方式在較長時間內將藥物定向輸送到疾病部位，從而提高患者的依從性和治療效果。這促使了對新型水凝膠系統的研究。透過使用水凝膠，可以克服傳統劑型的限制。然而，高昂的研究成本和醫療核准規定限制了市場的成長。利用響應外部觸發的先進聚合物技術，可以開發出更先進的水凝膠。應用範圍正在擴展到 3D 細胞培養、植入和農業化學品輸送。
本研究的主要特點
本報告對全球基於水凝膠的藥物輸送系統市場進行了詳細分析，並提供了預測期（2025-2032）的市場規模和年複合成長率（CAGR%），假設 2024 年為基準年。
它還揭示了各個領域的潛在商機，並解釋了該市場的有吸引力的投資提案矩陣。
它還提供了關於市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景和主要企業採用的競爭策略的主要考察。
全球水凝膠基藥物輸送系統市場的關鍵參與者根據公司亮點、產品系列、關鍵亮點、財務表現和策略等參數進行分析。
主要企業包括 Ocular Therapeutix, Inc.、Medtronic、Ferring BV、Pfizer, Inc.、Teva Pharmaceutical Industries Ltd.、ProLynx Inc.、Neurelis, Inc.、Micropore Technologies 和 Bausch Health Companies Inc.
本報告的見解將使負責人和企業經營團隊能夠就未來產品發布、新興趨勢、市場擴張和行銷策略做出明智的決策。
本研究報告研究了全球基於水凝膠的藥物輸送系統市場，並提供給該行業的各個相關利益者，例如投資者、相關人員、產品製造商、經銷商、新進業者和財務分析師。
相關人員將透過用於分析全球水凝膠藥物輸送系統市場的各種策略矩陣來做出決策。
目錄
第1章 調查目的與前提條件
- 研究目標
- 先決條件
- 簡稱
第2章 市場展望
- 報告描述
- 市場定義和範圍
- 執行摘要
第3章市場動態、法規與趨勢分析
- 市場動態
- 影響分析
- 主要亮點
- 監管情景
- 產品發布/核准
- PEST分析
- PORTER 分析
- 併購情景
4. 全球以水凝膠為基礎的藥物傳遞系統市場，依來源分類，2020-2032 年（十億美元）
- 自然的
- 合成
- 混合
5. 全球以水凝膠為基礎的藥物傳遞系統市場，按應用分類，2020-2032 年（十億美元）
- 心臟病學
- 腫瘤學
- 免疫學
- 疼痛管理
- 其他
6. 全球以水凝膠為基礎的藥物傳遞系統市場，以輸送途徑，2020-2032 年（十億美元）
- 皮下
- 眼科
- 口服
- 外用
- 其他
7. 2020 年至 2032 年全球基於水凝膠的藥物輸送系統市場（按最終用戶分類）（十億美元）
- 醫院
- 專科門診
- 其他
8. 2020 年至 2032 年全球基於水凝膠的藥物輸送系統市場，按地區分類，價值（十億美元）
- 北美洲
- 拉丁美洲
- 歐洲
- 亞太地區
- 中東
- 非洲
第9章 競爭格局
- Ocular Therapeutix, Inc.
- Medtronic
- Ferring BV
- Pfizer, Inc.
- Teva Pharmaceutical Industries Ltd.
- ProLynx Inc.
- Neurelis, Inc.
- Micropore Technologies
- Bausch Health Companies Inc.
第 10 章分析師建議
- 機會
- 分析師觀點
- Coherent Opportunity Map
第 11 章 參考文獻與調查方法
- 參考
- 調查方法
- 關於出版商
Global Hydrogel-Based Drug Delivery System Market is estimated to be valued at USD 8.49 Bn in 2025 and is expected to reach USD 13.47 Bn by 2032, growing at a compound annual growth rate (CAGR) of 6.8% from 2025 to 2032.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2024 | Market Size in 2025: | USD 8.49 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2025 To 2032 |
| Forecast Period 2025 to 2032 CAGR: | 6.80% | 2032 Value Projection: | USD 13.47 Bn |
Hydrogel-based drug delivery system is an emerging technology that involves the use of hydrogels as a carrier for drug encapsulation and delivery. Hydrogels are hydrophilic, polymeric networks that can absorb large amounts of water or biological fluids, but maintain their structure. They mimic the natural extracellular matrix and can encapsulate cells and drugs to be released in a sustained and localized manner. Advantages of hydrogel-based delivery include protection of drugs from degradation, controlled release kinetics that prolong therapeutic activity, better targeting to specific body sites, and compatibility with biological systems. Industries are actively researching hydrogel formulations for various drugs and new applications in tissue engineering, wound healing, and biosensing.
Market Dynamics:
The hydrogel-based drug delivery system market is primarily driven by the rising demand for localized and sustained drug delivery. Hydrogels allow targeted delivery of drugs to disease sites in a controlled release manner over extended periods, improving patient compliance and treatment outcomes. This fosters research into novel hydrogel systems. Limitations of conventional dosage forms can be overcome by using hydrogels. However, high research costs and medical approval regulations restrain market growth. Opportunities lie in developing sophisticated hydrogels using advanced polymer technology, responding to external triggers. Applications are expanding into 3D cell culture, implants, and agrochemical delivery.
Key Features of the Study:
This report provides in-depth analysis of the global hydrogel-based drug delivery system market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global hydrogel-based drug delivery system market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Ocular Therapeutix, Inc., Medtronic, Ferring B.V., Pfizer, Inc., Teva Pharmaceutical Industries Ltd., ProLynx Inc., Neurelis, Inc., Micropore Technologies, Bausch Health Companies Inc.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global hydrogel-based drug delivery system market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global hydrogel-based drug delivery system market
Market Segmentation
- By Source Insights (Revenue, USD Bn, 2020 - 2032)
- Natural
- Synthetic
- Hybrid
- By Application Insights (Revenue, USD Bn, 2020 - 2032)
- Cardiology
- Oncology
- Immunology
- Pain Management
- Others
- By Route of Delivery Insights (Revenue, USD Bn, 2020 - 2032)
- Subcutaneous
- Ocular
- Oral
- Topical
- Others
- By End User Insights (Revenue, USD Bn, 2020 - 2032)
- Hospitals
- Specialty clinics
- Others
- Regional Insights (Revenue, USD Bn, 2020 - 2032)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Ocular Therapeutix, Inc.
- Medtronic
- Ferring B.V.
- Pfizer, Inc.
- Teva Pharmaceutical Industries Ltd.
- ProLynx Inc.
- Neurelis, Inc.
- Micropore Technologies
- Bausch Health Companies Inc.
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Hydrogel-Based Drug Delivery System Market, By Source
- Hydrogel-Based Drug Delivery System Market, By Application
- Hydrogel-Based Drug Delivery System Market, By Route of Delivery
- Hydrogel-Based Drug Delivery System Market, By End User
- Hydrogel-Based Drug Delivery System Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
4. Global Hydrogel-Based Drug Delivery System Market, By Source, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Natural
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Synthetic
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Hybrid
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
5. Global Hydrogel-Based Drug Delivery System Market, By Application, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Cardiology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Oncology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Immunology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Pain Management
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
6. Global Hydrogel-Based Drug Delivery System Market, By Route of Delivery, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Subcutaneous
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Ocular
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Topical
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
7. Global Hydrogel-Based Drug Delivery System Market, By End User, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Specialty clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
8. Global Hydrogel-Based Drug Delivery System Market, By Region, 2020 - 2032, Value (USD Bn)
- Introduction
- Market Share (%) Analysis, 2025,2028 & 2032, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Bn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Source, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Route of Delivery, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Source, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Route of Delivery, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Source, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Route of Delivery, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Source, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Route of Delivery, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Source, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Route of Delivery, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Source, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Route of Delivery, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Bn)
- South Africa
- North Africa
- Central Africa
9. Competitive Landscape
- Ocular Therapeutix, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Medtronic
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Ferring B.V.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Pfizer, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Teva Pharmaceutical Industries Ltd.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- ProLynx Inc.
- Neurelis, Inc.
- Micropore Technologies
- Bausch Health Companies Inc.
10. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
11. References and Research Methodology
- References
- Research Methodology
- About us
